Security key
G7709Q104
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)
CUSIP: G7709Q104
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 300,556,312
- Total 13F value
- $8,159,558,450
- Share change
- -3,048,146
- Put/Call ratio
- 16%
- SEC-reported price per share
- $27.14
- Number of holders
- 312
- Value change
- -$95,718,367
- Number of buys
- 168
- Number of sells
- 156
- Shares outstanding
- 445,144,313
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
312
Top holders
10
RPRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Royalty Pharma plc SEC filings
Royalty Pharma plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP G7709Q104
Recent filing periods:
Ownership snapshot
Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
11%
VANGUARD GROUP INC
8.7%
FMR LLC
7.6%
BlackRock Finance, Inc.
4.7%
BAILLIE GIFFORD & CO
4.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
11%
|
$1,457,994,028
47,429,861 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
8.7%
|
$1,194,181,249
38,847,796 shares
|
— | 30 Jun 2023 |
| FMR LLC |
13F
Company
|
7.6%
|
$1,041,601,849
33,884,250 shares
|
— | 30 Jun 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
4.7%
|
$637,594,299
20,741,519 shares
|
— | 30 Jun 2023 |
| BAILLIE GIFFORD & CO |
13F
Company
|
4.2%
|
$568,708,076
18,500,588 shares
|
— | 30 Jun 2023 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
2.2%
|
$302,817,650
9,850,932 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
312
Shares
300,556,312
Rows available
312
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
321
Q3 2023 holders
312
Holder diff
-9
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend